Related Experiment Videos
Early endothelial dysfunction following renal mass reduction in rats
S Benchetrit1, J Green, D Katz
1Department of Nephrology and Hypertension, Meir Hospital-Sapir Medical Center, 44281 Kfar Saba, Israel.
European Journal of Clinical Investigation
|December 21, 2002
Summary
Renal mass reduction causes early endothelial dysfunction in rats, even with normal sodium intake. This dysfunction is linked to reduced nitric oxide availability, with prostacyclin production compensating.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Endothelial Function
Background:
- Endothelial dysfunction is known in hypertensive rats with renal mass reduction (RMR) and high sodium intake.
- The specific impact of renal failure on endothelium-dependent vasodilation, independent of hypertension and sodium, remains unclear.
Purpose of the Study:
- To investigate the early effects of renal mass reduction (RMR) on endothelium-dependent vasodilation in rats.
- To determine the role of nitric oxide, prostacyclin, and endothelium-derived hyperpolarizing factor (EDHF) in mediating these changes.
Main Methods:
- Mesenteric arteries from RMR and sham-operated (SN) rats were studied for responses to acetylcholine.
- The involvement of nitric oxide (L-NAME), prostacyclin (indomethacin), and EDHF (charybdotoxin/apamin) was assessed using specific inhibitors.
- Urinary and perfusate levels of 6-keto prostaglandin F1alpha were measured.
Main Results:
- Acetylcholine-induced relaxation was impaired in RMR rats compared to SN rats.
- Nitric oxide inhibition (L-NAME) further reduced relaxation in SN but not RMR rats.
- Prostacyclin inhibition (indomethacin) impaired relaxation in RMR rats but not SN rats, with elevated prostaglandin levels observed in RMR rats.
Conclusions:
- Endothelial dysfunction develops early after RMR, even with minimal hypertension and normal sodium intake.
- This dysfunction may stem from decreased nitric oxide availability.
- Increased prostacyclin production appears to partially compensate for the impaired vasodilation.